November 4th 2022
A panel of infectious disease experts examines the risks and implications of multi-drug resistant HIV and discusses emerging treatment strategies that could shape clinical approaches in the future.
October 24th 2022
Expert health professionals provide key insights on recently approved SARS-CoV-2 booster shots highlighting current recommendations and optimizing patient communication and education on vaccination options.
July 26th 2022
Dr. Feuerstadt, a gastroenterologist, discusses foundational trials and ongoing studies in the use of fecal microbial transplantation (FMT) for treatment of recurrent C. difficile infections.
December 23rd 2021
A panel of experts provides a thorough discussion on COVID-19 booster shots, including eligibility and safety considerations.
November 22nd 2021
Expert panelists provide insight on the relationship between the gut microbiome and c difficile, leading to the development of novel therapeutic approaches for infection.
August 17th 2021
Importance of patient education and early testing to differentiate between influenza and COVID-19.
August 3rd 2021
An expert multidisciplinary panel reacts to the availability of newer therapies and various strategies that may minimize adverse effects, including weight gain, from HIV treatment.
January 8th 2021
March 27th 2020
March 19th 2019
Broaching the Subject of Antibiotic Allergy Challenges with Patients
Pfizer-BioNTech Asks FDA to Authorize Omicron Bivalent COVID-19 Booster for Children Under 5 Years
Enterococcus Coinfection Enhances C Difficile Infection Severity
FDA Expands Use of Vemlidy to Adolescents with Chronic HBV Infection
